Superseded public profile

In clinical trials↗Metabolic↗

Superseded · version 1: Maridebart cafraglutide↗

Related names recorded in this version: MariTide, AMG 133↗

An antibody-peptide conjugate candidate represented in ClinicalTrials.gov.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.

What this version reported

ClinicalTrials.gov lists an Amgen bioavailability study as completed, updated July 21, 2026.↗

Organizations named in cited records:

Trial records: NCT07717814

Sources for this version

  1. 1
    Bioavailability of AMG 133 in Participants With Overweight or Obesity · record history version 1 · last update posted 2026-07-21 ↗

    ClinicalTrials.gov · Official source · Source checked July 22, 2026